AMP-activated protein kinase modulators: a patent review (2006 –– 2010)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.7, 2011-07, pp. : 983-1005

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct AMP-activated protein kinase activators: a review of evidence from the patent literature

By Giordanetto Fabrizio Karis David

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1467-1477

Informa Healthcare

Access to resources Recommend Favorite

AMP-Activated Protein Kinase and Type 2 Diabetes

Current Medicinal Chemistry, Vol. 13, Iss. 5, 2006-03 ,pp. : 583-589

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like receptor modulators: a patent review (2006 –– 2010)

By Basith Shaherin Manavalan Balachandran Lee Gwang Kim Sang Geon Choi Sangdun

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 927-944

Informa Healthcare

Access to resources Recommend Favorite

Farnesyl pyrophosphate synthase modulators: a patent review (2006 – 2010)

By Sun Shuting McKenna Charles E

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1433-1451

Informa Healthcare

Access to resources Recommend Favorite

Prolonged AMP-activated protein kinase induction impairs vascular functions

By Ertuna Elif

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 12, 2013-01 ,pp. : 1025-1030

NRC Research Press

Access to resources Recommend Favorite